About this medicine

Nerve-pain treatment and depression treatment use different dose ranges. Pamelor is a retained US search alias, not a verified UK brand here.

What is this medicine used for?

The exact Blackrock licence is for depression. Nerve-pain use described by the NHS is off-label for these products; their SmPC does not recommend childhood depression treatment.

Which warning signs need help?

Get urgent advice after any excess dose. Collapse, seizures, breathing difficulty or a fast irregular heartbeat need emergency assessment. New self-harm thoughts also require immediate help.

MHRA’s October 2026 communication announced the rollout of a prominent boxed warning in UK antidepressant patient leaflets about self-harm and suicidal behaviour, alongside a patient safety card. This UK patient-information measure is not the US FDA Boxed Warning designation. Read the leaflet supplied with your medicine, seek prompt professional help for new or worsening mood or behaviour changes, and do not stop treatment suddenly without advice.

How do I take it safely?

Blackrock tablet depression reference: start low, for example 50 mg once daily or 25 mg two to three times daily, and increase cautiously. Doses above 150 mg daily are not recommended. Older patients start at 10–20 mg daily. These are prescribing references, not personal instructions.

Flamingo’s 50 mg tablet is another checked UK presentation licensed for adult major depressive episodes, not for under-18s. It does not make 50 mg the right starting amount for every patient. Dose selection, cardiac precautions and monitoring remain necessary regardless of tablet strength.

Liquid availability needs particular care: the former Colonis 10 mg/5 ml and 25 mg/5 ml solutions are currently marked discontinued. A 2024 NHS/DHSC supply notice described unlicensed special suspensions as possible alternatives. It is not evidence of today’s stock. A prescriber and pharmacist must confirm a suitable preparation, its concentration and licensing status for someone who cannot swallow tablets; do not assume any liquid is interchangeable.

What side effects should I know about?

Dry mouth, constipation, sweating, dizziness, blurred vision, sexual difficulties and weight changes can occur.

MHRA is adding the term post-SSRI sexual dysfunction (PSSD) to patient leaflets describing persistent sexual difficulties after stopping certain antidepressants, including this medicine. Their frequency and causes remain under study. Persistent symptoms deserve support; this does not mean everyone taking the medicine will experience them.

Who needs extra care with this medicine?

Discuss heart disease, epilepsy, glaucoma, urinary retention, thyroid problems and previous mania. Brugada syndrome or a family history of sudden cardiac death is particularly relevant.

Recent heart attack, heart block or other cardiac arrhythmia are contraindications, not merely reasons for routine caution. Older people are particularly susceptible to confusion and blood-pressure falls on standing.

Can it affect my other medicines?

MAO inhibitors are incompatible. Other antidepressants, decongestants, sedatives and heart-rhythm medicines may interact; show the pharmacist a complete medicines list.

Fluoxetine can substantially raise nortriptyline concentrations and continues to matter after stopping because it clears slowly. Other anticholinergic medicines can worsen constipation, urinary problems and overheating. Tell the anaesthetic team before surgery.

What check-ups will I need?

The SmPC requires plasma-level monitoring above 100 mg daily. Mood, blood pressure, cardiac symptoms and adverse effects also need review.

Older people needing more than 50 mg/day require ECG and plasma-level checks under this product’s instructions. Clinical symptoms take precedence over a reassuring drug level. Fever or sore throat early in treatment can require a blood count.

What about pregnancy, breastfeeding and age?

Pregnancy or breastfeeding needs specialist discussion. The checked SmPC and leaflet differ in breastfeeding wording; do not use this summary to decide whether to start or stop treatment.

The SmPC allows breastfeeding when maternal benefit outweighs infant risk, while the leaflet is more restrictive. Pregnancy can change drug concentrations; monitoring may be needed. Use near delivery can cause newborn withdrawal or anticholinergic symptoms such as feeding, breathing, urinary or bowel difficulties.

What if I miss a dose or want to stop?

Take a missed dose when remembered unless the next is nearly due; never double up. Planned stopping is usually gradual over weeks or longer.

How does it work?

Nortriptyline slows reuptake, the return of chemical messengers into the nerve cells that released them. Its effect on noradrenaline reuptake is stronger than its effect on serotonin reuptake, changing the messages available between cells. This helps describe its action, but does not fully explain how symptoms improve or predict the response of an individual.

How Brain Cells Communicate

Nerve cells use chemical messengers called neurotransmitters to communicate across tiny gaps between cells. Receptors are proteins that detect the messages and change a cell’s activity. Transporters carry messengers into cells, while other processes control how they are stored and released. Together, these processes regulate the signals received by connected groups of nerve cells.

What is known: Communication depends on messenger release, transport, storage and receptor responses.

What remains uncertain: No single signaling process provides a complete explanation of depression.

How the process works

  1. Nerve-cell signal
  2. Receptor or transporter
  3. Network activity
Communication depends on messenger release, transport, storage and receptor responses. Simplified illustration of the process; individual responses vary.
About this illustration

Nerve-cell signal; Receptor or transporter; Network activity. No single signaling process provides a complete explanation of depression.

This is a simplified illustration. It does not show exactly how a medicine fits into a protein or predict a dose or response to treatment.

How the Medication Changes Signaling

Nortriptyline affects catecholamines, a family of chemical messengers that includes norepinephrine and dopamine. Its prescribing information describes effects on their transport, release and storage. It also reduces some actions of histamine, serotonin and acetylcholine, messengers involved in functions such as wakefulness, mood and bowel activity. This range of actions helps explain why a medicine can have several effects in the same person, without identifying one as the complete cause of antidepressant benefit.

What is known: Nortriptyline influences several chemical signaling systems.

What remains uncertain: Measured actions at different targets do not reveal which will matter most for one person.

How the process works

  1. Nortriptyline
  2. Molecular actions
  3. Clinical effects
Nortriptyline influences several chemical signaling systems. Simplified illustration of the process; individual responses vary.
About this illustration

Nortriptyline; Molecular actions; Clinical effects. Measured actions at different targets do not reveal which will matter most for one person.

This is a simplified illustration. It does not show exactly how a medicine fits into a protein or predict a dose or response to treatment.

A Closer Look at the Molecular Level

CYP2D6, an enzyme that helps process medicines, influences how much nortriptyline remains in the body. Its activity varies between people and can be reduced by other medicines, potentially raising nortriptyline levels. The amount of medicine reaching the body over time is called exposure; blood-level monitoring can help assess it, while symptoms and heart-related effects still need their own assessment. More medicine in the blood does not automatically mean more improvement.

What is known: Differences in drug processing can change nortriptyline exposure.

What remains uncertain: A blood concentration cannot replace assessment of benefits and adverse effects.

How the process works

  1. Dose and metabolism
  2. Drug exposure
  3. Benefit and harm
Differences in drug processing can change nortriptyline exposure. Simplified illustration of the process; individual responses vary.
About this illustration

Dose and metabolism; Drug exposure; Benefit and harm. A blood concentration cannot replace assessment of benefits and adverse effects.

This is a simplified illustration. It does not show exactly how a medicine fits into a protein or predict a dose or response to treatment.

How does it affect my body?

Its effects include dry mouth, constipation and changes in pulse or blood pressure. Dizziness can increase falls risk.

How does my body process it?

CYP2D6 activity varies between people. Liver impairment and interacting medicines can raise concentrations; the average elimination half-life is about 26 hours.

How do treatment options differ?

Pain doses described by the NHS are lower than many depression doses. Comparing tablet strengths alone can therefore be misleading.

A closer look at the science

Nortriptyline is also the main active metabolite of amitriptyline. Anticholinergic activity remains clinically important despite being less marked than amitriptyline’s.

Nortriptyline is a tricyclic amine supplied as a hydrochloride salt.

Chemical formula: C19H21N · HCl

The drawing depicts neutral nortriptyline, C19H21N; HCl is shown separately in the product formula.

PubChem 2D depiction of neutral nortriptyline; salt components omitted.
NCBI PubChem CID 4543. Lines are bonds; unlabeled corners are carbon and many hydrogen atoms are omitted. This neutral-parent drawing is connectivity, not a binding pose.

The drawing shows the neutral parent. The product salt formula is separately identified; neither determines release rate or dose.

How was this medicine developed?

This Blackrock authorisation record dates from January 2025; it does not mark nortriptyline’s original introduction.

Sources and References

  1. Nortriptyline 10 mg — UK SmPC

    Product information published on the electronic Medicines Compendium (emc); supplied by pharmaceutical companies.

    Scope: United Kingdom product information.

  2. Nortriptyline 25 mg — UK SmPC

    Product information published on the electronic Medicines Compendium (emc); supplied by pharmaceutical companies.

    Scope: United Kingdom product information.

  3. Nortriptyline — patient leaflet

    Product information published on the electronic Medicines Compendium (emc); supplied by pharmaceutical companies.

    Scope: United Kingdom product information.

  4. NHS: How and when to take nortriptyline

    Scope: NHS website medicines information (England); not a guarantee of identical services across UK nations.

  5. NHS: About nortriptyline

    Scope: NHS website medicines information (England); not a guarantee of identical services across UK nations.

  6. Antidepressants: use and safety

    Scope: United Kingdom.

  7. Nortriptyline 50 mg film-coated tablets — SmPC

    Product information published on the electronic Medicines Compendium (emc); supplied by pharmaceutical companies.

    Scope: United Kingdom; named product information.

  8. Nortriptyline 10 mg/5 ml oral solution — discontinued product record

    Product information published on the electronic Medicines Compendium (emc); supplied by pharmaceutical companies.

    Scope: United Kingdom; former named product.

  9. Nortriptyline 25 mg/5 ml oral solution — discontinued product record

    Product information published on the electronic Medicines Compendium (emc); supplied by pharmaceutical companies.

    Scope: United Kingdom; former named product.

  10. Nortriptyline oral solutions: discontinuation — MSN/2024/061

    Scope: England medicines-supply advice; historical notification, not a present UK stock guarantee.

  11. Nortriptyline hydrochloride capsules prescribing information — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: Clinical Pharmacology; Warnings; Drug Interactions—Drugs Metabolized by P450 2D6; Dosage and Administration..

  12. What Is a Neurotransmitter? — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: How Neurotransmitters Work; Types of Neurotransmitters..

  13. Nortriptyline: FDA prescribing information

    Scope: Shared scientific explanation; source remains US, not UK prescribing authority.

  14. Nortriptyline: verified neutral parent, PubChem CID 4543

    Scope: International chemical reference.

Shared scientific background. US product pharmacology and chemical references do not establish UK licences, doses, formulations or NHS recommendations.

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top